Premium
The differential expression of oestrogen receptors, progesterone receptors, Bcl‐2 and Ki67 in endometrial polyps
Author(s) -
Taylor Lydia J.,
Jackson Tracy L.,
Reid Janet G.,
Duffy Sean R.G.
Publication year - 2003
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2003.02098.x
Subject(s) - endometrium , endometrial polyp , receptor , immunohistochemistry , medicine , endocrinology , progesterone receptor , follicular phase , pathogenesis , menstrual cycle , biology , estrogen receptor , hormone , cancer , breast cancer
Objective To obtain a greater understanding of the pathogenesis of endometrial polyps and to gain insight into which factors play a pivotal role in their growth. Design Retrospective analysis of archived paraffin‐embedded specimens. Setting St James's University Hospital. Sample Thirty secretory phase endometrial samples, 10 secretory phase endometrial polyps, 8 proliferative phase endometrial samples and 10 proliferative phase endometrial polyps. Methods Immunohistochemistry was used to characterise the expression of oestrogen and progesterone receptors, Bcl‐2 and Ki67 in cycling endometrium and phase‐matched endometrial polyps. Patterns of expression were compared between the polyps and the endometrium. Main outcome measure The expression of oestrogen receptors, progesterone receptors, Bcl‐2 and Ki67. Results Three significant differences were found between the endometrium and the polyps. Polyps taken from the proliferative phase of the cycle displayed significantly elevated expression of Bcl‐2 and weak or no expression of progesterone receptors. Secretory phase polyps displayed an elevated expression of oestrogen receptors. Conclusion A localised increase in Bcl‐2 expression and consequential decline or cessation of apoptosis is an important mechanism underlying the pathogenesis of endometrial polyps. Elevated Bcl‐2 expression results in failure of the polyp tissue from undergoing normal cyclical apoptosis during the late secretory phase. This may mean the polyp is not shed along with the rest of the endometrium during menstruation.